CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 28 enrolled
Drug / intervention
cheese ingestionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00360919
NCT00360919Early Ph 1Completed
CompareCT.gov

Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion

Physicians Committee for Responsible Medicine·interventional·Posted Aug 7, 2006·Updated Aug 7, 2012

In Brief

A Early Phase 1 clinical trial evaluating cheese ingestion for Food Habits. Completed, enrolled 28 participants across 1 site.

Detailed Summary

This purpose of this study is to perform a pilot investigation to determine if opioid peptides such as casomorphin can be detected in human plasma after cheese ingestion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFood Habits
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 7, 2006
Enrollment StartSep 1, 2006
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 19.9 years ago

Interventions

cheese ingestionbehavioral

On study day 1, approximately half of the participants will consume a breakfast of fruits and vegetables, whereas the other half of participants will consume a meal consisting of 9 oz. of cheese. Blood samples will be collected from participants immediately prior to consumption of the meals, and then again at regular intervals for up to 8 hours following the meals. At least 3 days later, participants will return for study Day 2. The participants will receive the second meal. Blood samples will then be collected immediately prior to consumption of the test meal and for up to 8 hours after the meal.